Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04517877 · ClinicalTrials.gov registry record · Phase 2
Caring Light Project for Family Caregivers
A Phase 2 study of Alzheimer Disease, sponsored by Photozig.
- Completed
- Registry status
- Phase 2
- Development phase
- 164
- Enrollment target
- 1
- Study location
NCT04517877: Completed Phase 2 study of Alzheimer Disease, sponsored by Photozig.
NCT04517877 is a Phase 2 study of Alzheimer Disease that has completed, run by Photozig. The registered enrollment target is 164 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04517877, a Phase 2 study of Alzheimer Disease, has completed, sponsored by Photozig.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
Caring Light is designed to help caregivers of someone with Alzheimer's Disease and related dementia to cope with the difficulties related to caregiving, reduce stress, and improve quality of life.
Primary Outcome
The Center for Epidemiological Studies Depression scale (CES-D) is a 20-item measure that asks about the frequency of depressive symptoms (affective, psychological, and somatic) within the past week. The scale refers to the caregiver. Minimum score (best value)=0. Maximum score (worst value)=60. Higher values represent a worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Caring Response App
- BEHAVIORAL Traditional Educational/Resources Program
Study Locations (1)
California
- Photozig, Inc. - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2021-05-30 |
| Phase | Phase 2 |
What the finished NCT04517877 record still lists
NCT04517877 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Caring Response App is the first listed.
NCT04517877 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04517877 about?
NCT04517877 is a clinical study titled "Caring Light Project for Family Caregivers". Caring Light is designed to help caregivers of someone with Alzheimer's Disease and related dementia to cope with the difficulties related to caregiving, reduce stress, and improve quality of life.
What is the current status of trial NCT04517877?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 164 participants. The study started on 2020-07-15. Estimated completion is 2021-05-30.
What conditions does trial NCT04517877 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT04517877?
The interventions under investigation include: Caring Response App (BEHAVIORAL), Traditional Educational/Resources Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04517877?
This trial is sponsored by Photozig, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04517877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04517877's enrollment target sits among peer trials
164 122nd of 306 higher than 184 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
RECRUITING · Phase 2
-
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RECRUITING · Phase 2
-
Sleep Trial to Prevent Alzheimer's Disease
RECRUITING · Phase 2
-
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
RECRUITING · Phase 2
-
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05612594 · 164 participants · Phase 4
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI